Karen L. Smith - May 7, 2021 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Chief Medical Officer
Signature
/s/ S. Scott Lieberman, Attorney-in-fact
Stock symbol
EBS
Transactions as of
May 7, 2021
Transactions value $
-$18,559
Form type
4
Date filed
5/11/2021, 04:30 PM
Next filing
Jun 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability -$18.6K -305 -2.5% $60.85 11.9K May 7, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes upon vest of restricted stock units granted under the company's stock incentive plan, as amended and restated.